Your browser doesn't support javascript.
loading
Evaluation of the effect of antibiotics used during parenteral nutrition treatment on Candidemia.
Yalçin, Nadir; Sürmelioglu, Nursel; Özkan-Kuscu, Özlem; Kelleci-Çakir, Burcu; Demirkan, Kutay; Gündüz, Murat.
Afiliação
  • Yalçin N; Hacettepe University, Faculty of Pharmacy, Department of Clinical Pharmacy - Ankara, Turkey.
  • Sürmelioglu N; Çukurova University, Faculty of Pharmacy, Department of Clinical Pharmacy - Adana, Turkey.
  • Özkan-Kuscu Ö; Adana Seyhan State Hospital, Department of Intensive Care Unit - Adana, Turkey.
  • Kelleci-Çakir B; Hacettepe University, Faculty of Pharmacy, Department of Clinical Pharmacy - Ankara, Turkey.
  • Demirkan K; Hacettepe University, Faculty of Pharmacy, Department of Clinical Pharmacy - Ankara, Turkey.
  • Gündüz M; Çukurova University, Faculty of Medicine, Department of Anesthesiology and Reanimation - Adana, Turkey.
Rev Assoc Med Bras (1992) ; 67(10): 1448-1453, 2021 Oct.
Article em En | MEDLINE | ID: mdl-35018974
OBJECTIVE: Parenteral nutrition is an important risk factor for candidemia. In this risk analysis study, the effect of previous antibiotic administration apart from the length of hospital stay, duration of Parenteral nutrition treatment, and Candida score parameters on developing candidemia was evaluated in the non-neutropenic patients receiving Parenteral nutrition treatment. METHODS: In this double center, retrospective, and cross-sectional study, the data of patients who received Parenteral nutrition treatment were collected. Patients with or without candidemia after the initiation of Parenteral nutrition treatment were compared in terms of demographic features, Candida score, length of hospital stay, duration of Parenteral nutrition treatment, and previous use of antibiotics. Then, predictor factors affecting the probability of candidemia during Candida growth time were determined by the Cox regression analysis. RESULTS: A total of 148 patients (59.5% males) were included and 16 (10.81%) of these had candidemia after initiation of parenteral nutrition treatment. The median (min-max) duration of parenteral nutrition treatment was 11 (4-72) days and the Candida growth time was 13 (7-29) days. Statistically significant differences were found between patients with or without candidemia groups in terms of length of hospital stay (p<0.001), duration of parenteral nutrition treatment (p<0.001), and Candida score (p<0.001). To determine the effect of these variables and antibiotics on candidemia, length of hospital stay [Hazard Ratio 1.030; p=0.021] and piperacillin-tazobactam (Hazard Ratio 5.626; p=0.030) were found significant and independent risk factors on the development of candidemia. CONCLUSION: There are some well-known risk factors including length of hospital stay, duration of Parenteral nutrition treatment, and Candida score; the potential impact of piperacillin-tazobactam administration should also be considered since they may be effective on the development of candidemia.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candidemia Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia País de publicação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Candidemia Tipo de estudo: Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Turquia País de publicação: Brasil